Skip to main content
. 2020 Mar 18;8:e8816. doi: 10.7717/peerj.8816

Table 10. Correlation of NFIs with survival outcomes in esophageal cancer patients.

Gene RNAseq ID Survival outcome No. of cases Cut-off value HR 95% CI p-Value
(A) Correlation of NFIs with survival outcomes in esophageal squamous cell carcinoma patients
NFIA 4774 OS 81 2,029 0.64 [0.27–1.55] 0.32
RFS 54 1,211 0.57 [0.22–1.49] 0.25
NFIB 4781 OS 81 2,102 0.51 [0.21–1.24] 0.13
RFS 54 2,422 0.31 [0.09–1.1] 0.056
NFIC 4782 OS 81 7,712 0.45 [0.18–1.13] 0.08
RFS 54 9,377 1.45 [0.53–3.91] 0.47
NFIX 4784 OS 81 4,135 0.72 [0.3–1.73] 0.46
RFS 54 4,135 0.35 [0.1–1.24] 0.09
(B) Correlation of NFIs with survival outcomes in esophageal adenocarcinoma patients
NFIA 4774 OS 80 2,000 0.6 [0.31–1.15] 0.12
RFS 19 2,161 6.57 [0.66–65.46] 0.068
NFIB 4781 OS 80 2,571 1.46 [0.76–2.79] 0.25
RFS 19 4,327 3.03 [0.42–21.68] 0.25
NFIC 4782 OS 80 3,741 0.44 [0.22–0.9] 0.02
RFS 19 3,579 271493742 [0–lnf.] 0.28
NFIX 4784 OS 80 3,353 0.33 [0.16–0.68] 0.0017
RFS 19 3373 0 [0–lnf.] 0.018

Note:

HR, hazard ratio; CI, confidence interval; OS, overall survival; RFS, relapse free survival.